APITBIO, Inc.
PrivateLast Round
Strategic
Dec 6, 2024
Total Funding Raised
$17.17M
Company Overview
APITBIO, Inc. operates in Healthcare & Life Sciences and is based in Seoul. Its latest recorded funding round was a Strategic round in December 2024.
APITBIO, Inc. is a biotechnology company that develops antibody-based therapeutics for cancer and infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
APITBIO, Inc. Comparables
Compare APITBIO, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Y-Biologics | 80% | |
| Phanes Therapeutics | 79% | |
| Aimed Bio Inc. | 78% |
For institutional investors. Book with your work email.
APITBIO, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Dec 6, 2024 | ||||
| Grant | Apr 30, 2024 | ||||
| Series A | Feb 8, 2021 | ||||
| Seed | Jul 1, 2019 | ||||
| Angel | Mar 1, 2019 |
For institutional investors. Book with your work email.
APITBIO, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KDB Capital Corp | Series A |
| Shinhan Venture Investment | Series A, Seed |
| UTC Investment | Series A |
| Mirae Equity Partners | Series A |
| KB Securities | Series A |
| Hyundai Technology Investment | Series A |
| Kolon Investment | Series A, Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors increased 53% MoM.
- May 19, 2026
Monthly visitors increased 634% MoM, from 237 to 1.7K.
For institutional investors. Book with your work email.
APITBIO, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about APITBIO, Inc.'s valuation, stock price, and market status.
Is APITBIO, Inc. a public or private company?
APITBIO, Inc. is a private company.
What is the current stock price of APITBIO, Inc.?
APITBIO, Inc. is a private company, so its shares have no public market price. Caplight tracks APITBIO, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is APITBIO, Inc. worth (valuation)?
Valuation information for APITBIO, Inc. is not publicly available.
Can I buy APITBIO, Inc. stock?
APITBIO, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was APITBIO, Inc.'s last funding round?
APITBIO, Inc.'s most recent funding round was Strategic on December 6, 2024.
Who are the main investors in APITBIO, Inc.?
Key investors in APITBIO, Inc. include KDB Capital Corp, Shinhan Venture Investment, UTC Investment, Mirae Equity Partners, KB Securities.
Will APITBIO, Inc. IPO soon?
No public IPO plans have been announced for APITBIO, Inc..
How can I track APITBIO, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in APITBIO, Inc.'s shares on secondary markets.